Blog

ENDOSCOPIC ADVANCES IN THE MANAGEMENT OF PANCREATIC CANCER

ENDOSCOPIC ADVANCES IN THE MANAGEMENT OF PANCREATIC CANCER

Disclaimer: Please note that Mya Care does not provide medical advice, diagnosis, or treatment. The information provided is not intended to replace the care or advice of a qualified health care professional. Always consult your doctor for all diagnoses, treatments, and cures for any diseases or conditions, as well as before changing your health care regimen. Do not reproduce, copy, reformat, publish, distribute, upload, post, transmit, transfer in any manner or sell any of the materials in this blog without the prior written permission from myacare.com.

Pancreatic Ductal Adenocarcinoma (PDAC) is the most common type of cancer of the Pancreas. It is an aggressive and difficult malignancy to treat and accounts for more than 90% of the pancreatic cancer cases. The incidence of PDAC has increased by 0.3% since 2006 and by 2030, it is expected to become the second cause of cancer related deaths in the United States. 

PDAC develops from the cells lining the small tubes in the pancreas called ducts, that carry the digestive juices, containing the enzymes, to the main pancreatic duct and duodenum. 

With high mortality rate and poor long-term survival of PDAC, medical experts have been developing various methods of diagnostics and treatment for this disease.

Read more about Endoscopic advances in the management of pancreatic cancer by Bumrungrad Hospital - Thailand

Inquire Now